STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about ACTG
Insiders, 180 days
-$457.6K net sold
2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$848.9K
5 notices
Acacia Research insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, ACACIA RESEARCH CORP insiders sold a net $457.6K of stock across 20 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jun 11, 2025.
The trade is 41.1% of the 78,310 shares held after it.
1 other insider sold within 30 days.
Insider activity: Director Kohlberg Isaac T. sold about $150.3K of ACTG on Aug 12, 2026, the largest insider sale at the company on our record; 1 other insider sold within 30 days.
20 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
ACTG planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Kohlberg Isaac T.
Filed 2026-09-15
$110.0K
Maureen E O'Connell
Filed 2026-09-02
$148.5K
Maureen E. O'Connell
Filed 2026-08-19
$45.0K
Kohlberg Isaac T.
Filed 2026-08-12
$150.2K
GEOFFREY RIBAR
Filed 2026-08-11
$395.2K
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $457.6K sold by insiders over 180 days, $848.9K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$278.4M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM ACTG
FY Dec 2025
$285.2M
FY Dec 2024
$122.3M
FY Dec 2023
$125.1M
FY Dec 2022
$59.2M
FY Dec 2021
$88.0M
Jun 2026
$114.6M
Mar 2026
$54.2M
Dec 2025
$50.1M
Sep 2025
$59.4M
Jun 2025
$51.2M
Mar 2025
$124.4M
Dec 2024
$48.8M
Sep 2024
$23.3M
At each fiscal year end
Single quarter
Net margin, TTM
-4.4%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM ACTG
FY Dec 2025
+8.6%
FY Dec 2024
-28.4%
FY Dec 2023
+55.1%
FY Dec 2022
-211.2%
FY Dec 2021
+169.5%
Jun 2026
+0.0%
Mar 2026
-29.0%
Dec 2025
+12.4%
Sep 2025
-4.6%
Jun 2025
-6.4%
Mar 2025
+19.5%
Dec 2024
-24.7%
Sep 2024
-60.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$120.5M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM ACTG
FY Dec 2025
-$75.2M
FY Dec 2024
-$98.5M
FY Dec 2023
-$22.7M
FY Dec 2022
-$38.1M
FY Dec 2021
$13.2M
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
$335.0K
Dec 2024
-$23.6M
Sep 2024
-$2.8M
At each fiscal year end
Single quarter
Debt to equity
0.17x
LongTermDebt as filed 2026-06-30 (includes the current portion); equity 2026-06-30
Debt to equity ACTG
FY Dec 2025
0.17x
FY Dec 2024
0.00x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
0.17x
Mar 2026
0.17x
Dec 2025
0.17x
Sep 2025
0.00x
Jun 2025
0.00x
Mar 2025
0.00x
Dec 2024
0.00x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.33x
TTM operating cash flow over LongTermDebt as filed 2026-06-30 (includes the current portion)
Cash flow to debt ACTG
FY Dec 2025
0.82x
FY Dec 2024
20.88x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
0.33x
Mar 2026
0.84x
Dec 2025
0.82x
Sep 2025
n/a
Jun 2025
13.20x
Mar 2025
-0.95x
Dec 2024
20.88x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-2.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity ACTG
FY Dec 2025
+4.6%
FY Dec 2024
-6.4%
FY Dec 2023
+16.7%
FY Dec 2022
-36.9%
FY Dec 2021
+42.8%
Jun 2026
-2.3%
Mar 2026
-2.9%
Dec 2025
+4.6%
Sep 2025
+1.1%
Jun 2025
-0.9%
Mar 2025
-1.8%
Dec 2024
-6.4%
Sep 2024
+10.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-1.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets ACTG
FY Dec 2025
+3.2%
FY Dec 2024
-5.0%
FY Dec 2023
+12.3%
FY Dec 2022
-19.5%
FY Dec 2021
+22.8%
Jun 2026
-1.6%
Mar 2026
-2.0%
Dec 2025
+3.2%
Sep 2025
+0.8%
Jun 2025
-0.7%
Mar 2025
-1.4%
Dec 2024
-5.0%
Sep 2024
+8.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital ACTG
FY Dec 2025
+1.5%
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
+1.5%
Sep 2025
+1.0%
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-2.7%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed ACTG
FY Dec 2025
+0.9%
FY Dec 2024
-5.0%
FY Dec 2023
+4.2%
FY Dec 2022
-8.1%
FY Dec 2021
+3.0%
Jun 2026
-2.7%
Mar 2026
-5.6%
Dec 2025
+0.9%
Sep 2025
+0.5%
Jun 2025
-0.0%
Mar 2025
+1.1%
Dec 2024
-5.0%
Sep 2024
+6.5%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing ACTG
FY Dec 2025
17.00x
FY Dec 2024
n/a
FY Dec 2023
11.20x
FY Dec 2022
n/a
FY Dec 2021
3.69x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
17.00x
Sep 2025
54.17x
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
7.90x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$189.2M
market value at close 2026-10-26 on 2026-08-03 shares, plus LongTermDebt as filed 2026-06-30 (includes the current portion), minus cash 2026-06-30
Enterprise value ACTG
FY Dec 2025
$145.9M
FY Dec 2024
$151.1M
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
$233.4M
Mar 2026
$247.6M
Dec 2025
$145.9M
Sep 2025
$11.7M
Jun 2025
$30.0M
Mar 2025
$37.9M
Dec 2024
$151.1M
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-29.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield ACTG
FY Dec 2025
-20.9%
FY Dec 2024
-23.3%
FY Dec 2023
-5.8%
FY Dec 2022
-20.8%
FY Dec 2021
+5.2%
Jun 2026
-26.8%
Mar 2026
-16.0%
Dec 2025
-20.9%
Sep 2025
-34.7%
Jun 2025
-34.5%
Mar 2025
-49.7%
Dec 2024
-23.3%
Sep 2024
-17.0%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing ACTG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
ACTG ranks highest on growth (94th percentile) and financial health (60th), and lowest on insider conviction (25th), among Services peers.
Profitability
37
Inputs
Return on equity-2.3% · 34 pct, sector of 207
Return on assets-1.6% · 43 pct, sector of 269
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-2.7% · 33 pct, sector of 203
Financial health
60
Inputs
Debt to equity0.17x · 62 pct, sector of 228
Cash flow to debt0.33x · 58 pct, sector of 199
Growth
94
Inputs
Revenue growth, YoY+133.2% · 94 pct, sector of 341
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
25
Inputs
Net Form 4 buying (codes P and S), 180d-$458K · 50 pct, sector of 174
Insider buyers, 180d0 · 0 pct, sector of 179
Risk and compliance
47
Inputs
Short interest, % of float+5.1% · 36 pct, sector of 383
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+9.4% · 58 pct, sector of 227
2 not measured: Institutional and government, US patents
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
ACTG filings, in plain words
Are Acacia Research insiders buying or selling ACTG?
In the 180 days to 2026-10-27, Acacia Research insiders were net sellers, a net $457.6K across purchases and sales reported on Form 4, by 2 sellers.
Are there planned insider sales of ACTG?
Yes. 5 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $848.9K of stock; the latest, by Kohlberg Isaac T., was filed 2026-09-15.
Read the full summary
In the 180 days to 2026-10-27, Acacia Research insiders were net sellers of ACTG, a net $457.6K across purchases and sales reported on Form 4 by 2 sellers. None of the 5 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 5 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $848.9K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.